Research Isn’t Abstract Science But a Pathway to Answers, Treatments, and Hope – ASH
American Society of Hematology shared a post on LinkedIn:
“On Rare Disease Day, let’s remember that research isn’t abstract science but a pathway to answers, treatments, and hope.
For people living with rare blood disorders, every new study, discovery, and clinical trial brings us closer to better diagnostics, safer therapies, and improved quality of life.
The ASH Research Awards Fund supports innovative research that can transform care for rare blood diseases—from early-stage ideas to breakthrough treatments.
When you give, you’re directly fueling the work that patients and families are counting on.
Your support helps to:
- Advance promising research in rare blood disorders
- Accelerate the development of new treatment options
- Bring hope to patients and families worldwide
Together, we can turn rare disease research into real-world impact for the people who need it most.”
Other posts about American Society of Hematology on Hemostasis Today.
-
Jun 11, 2026, 16:34Joao Mariano Pego: Advancing Coagulation Diagnostics Through Standardized Thrombin Generation
-
Jun 11, 2026, 16:33Ifeanyichukwu Ifechidere: Nobody Talks About Thrombosis in Sickle Cell Disease
-
Jun 11, 2026, 16:31Karim Mahawish: Ischaemic Stroke Despite Anticoagulation in Atrial Fibrillation
-
Jun 11, 2026, 16:29Salim Virani: The 2026 ACC/AHA Multisociety Dyslipidemia Guideline Promotes Early Prevention
-
Jun 11, 2026, 16:25Toyosi Onwuemene: What Clinicians Reveal About Bleeding and Clotting Care
-
Jun 11, 2026, 16:20Tejas Ahire: Rh Incompatibility – A Small Blood Group Difference with Big Clinical Impact
-
Jun 11, 2026, 16:19Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
-
Jun 11, 2026, 15:50Shatri Albertina: New Publication on DVT Among Surgical Patients Receiving Thromboprophylaxis
-
Jun 11, 2026, 15:48Ghada Eladly: The Classic Triad of Hemolytic Uremic Syndrome